Pulmonary delivery for the treatment of tuberculosis
Tuberculosis (TB) has gained attention over the past few decades by becoming one of the top ten leading causes of death worldwide. This infectious disease of the lungs is orally treated with a medicinal armamentarium. However, this route of administration passes through the body’s first-pass metabol...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/137335 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-137335 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1373352023-03-04T16:44:40Z Pulmonary delivery for the treatment of tuberculosis Poh, Wilson Kwok Choon Loo Say Chye Joachim School of Materials Science & Engineering joachimloo@ntu.edu.sg Engineering::Materials::Biomaterials Tuberculosis (TB) has gained attention over the past few decades by becoming one of the top ten leading causes of death worldwide. This infectious disease of the lungs is orally treated with a medicinal armamentarium. However, this route of administration passes through the body’s first-pass metabolism which reduces the drugs’ bioavailability and taxes the liver and kidneys. Inhalation therapy represents an alternative to the oral route, but low deposition efficiencies of delivery devices such as nebulizers and dry powder inhalers render it challenging as a favourable therapy. It is hypothesized that by encapsulating two potent TB-agents, i.e. Q203 and Bedaquiline, that inhibit the oxidative phosphorylation of the bacteria together with a magnetic targeting component, Superparamagnetic Iron Oxides (SPIOs), into a PDLG carrier using a single emulsion technique, the treatment of TB can be a better therapeutic alternative. This simple fabrication method achieved a homogenous distribution of 500 nm particles with a magnetic saturation of 28 emu/g. Such particles are shown to be magnetically susceptible in an in-vitro assessment, viable against A549 epithelial cells, and are able to reduce two log bacteria counts of the BCG organism. Furthermore, through the use of an external magnet, our in-silico Computational Fluid Dynamics (CFD) simulations support the notion of yielding close to a 100% deposition in the deep lungs. Our proposed inhalation therapy circumvents challenges related to oral and respiratory treatments and embodies a highly favourable new treatment regime. Doctor of Philosophy 2020-03-18T04:36:30Z 2020-03-18T04:36:30Z 2019 Thesis-Doctor of Philosophy Poh, W. K. C. (2019). Pulmonary delivery for the treatment of tuberculosis. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/137335 10.32657/10356/137335 en This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). application/pdf Nanyang Technological University |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Engineering::Materials::Biomaterials |
spellingShingle |
Engineering::Materials::Biomaterials Poh, Wilson Kwok Choon Pulmonary delivery for the treatment of tuberculosis |
description |
Tuberculosis (TB) has gained attention over the past few decades by becoming one of the top ten leading causes of death worldwide. This infectious disease of the lungs is orally treated with a medicinal armamentarium. However, this route of administration passes through the body’s first-pass metabolism which reduces the drugs’ bioavailability and taxes the liver and kidneys. Inhalation therapy represents an alternative to the oral route, but low deposition efficiencies of delivery devices such as nebulizers and dry powder inhalers render it challenging as a favourable therapy. It is hypothesized that by encapsulating two potent TB-agents, i.e. Q203 and Bedaquiline, that inhibit the oxidative phosphorylation of the bacteria together with a magnetic targeting component, Superparamagnetic Iron Oxides (SPIOs), into a PDLG carrier using a single emulsion technique, the treatment of TB can be a better therapeutic alternative. This simple fabrication method achieved a homogenous distribution of 500 nm particles with a magnetic saturation of 28 emu/g. Such particles are shown to be magnetically susceptible in an in-vitro assessment, viable against A549 epithelial cells, and are able to reduce two log bacteria counts of the BCG organism. Furthermore, through the use of an external magnet, our in-silico Computational Fluid Dynamics (CFD) simulations support the notion of yielding close to a 100% deposition in the deep lungs. Our proposed inhalation therapy circumvents challenges related to oral and respiratory treatments and embodies a highly favourable new treatment regime. |
author2 |
Loo Say Chye Joachim |
author_facet |
Loo Say Chye Joachim Poh, Wilson Kwok Choon |
format |
Thesis-Doctor of Philosophy |
author |
Poh, Wilson Kwok Choon |
author_sort |
Poh, Wilson Kwok Choon |
title |
Pulmonary delivery for the treatment of tuberculosis |
title_short |
Pulmonary delivery for the treatment of tuberculosis |
title_full |
Pulmonary delivery for the treatment of tuberculosis |
title_fullStr |
Pulmonary delivery for the treatment of tuberculosis |
title_full_unstemmed |
Pulmonary delivery for the treatment of tuberculosis |
title_sort |
pulmonary delivery for the treatment of tuberculosis |
publisher |
Nanyang Technological University |
publishDate |
2020 |
url |
https://hdl.handle.net/10356/137335 |
_version_ |
1759857977728172032 |